These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26965310)

  • 21. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease.
    Casali BT; Corona AW; Mariani MM; Karlo JC; Ghosal K; Landreth GE
    J Neurosci; 2015 Jun; 35(24):9173-81. PubMed ID: 26085639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease?
    Pomponi MF; Gambassi G; Pomponi M; Di Gioia A; Masullo C
    Ageing Res Rev; 2011 Jan; 10(1):124-31. PubMed ID: 20920611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?
    Miyazawa K; Fukunaga H; Tatewaki Y; Takano Y; Yamamoto S; Mutoh T; Taki Y
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients.
    Mizwicki MT; Liu G; Fiala M; Magpantay L; Sayre J; Siani A; Mahanian M; Weitzman R; Hayden EY; Rosenthal MJ; Nemere I; Ringman J; Teplow DB
    J Alzheimers Dis; 2013; 34(1):155-70. PubMed ID: 23186989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.
    Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS
    Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docosahexaenoic acid and the aging brain.
    Lukiw WJ; Bazan NG
    J Nutr; 2008 Dec; 138(12):2510-4. PubMed ID: 19022980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Varying Concentrations of Docosahexaenoic Acid on Amyloid Beta (1⁻42) Aggregation: An Atomic Force Microscopy Study.
    Lee BY; Attwood SJ; Turnbull S; Leonenko Z
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish.
    Pauwels EK; Volterrani D; Mariani G; Kairemo K
    Drug News Perspect; 2009 May; 22(4):205-13. PubMed ID: 19536365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease.
    Hashimoto M; Hossain S
    J Pharmacol Sci; 2011; 116(2):150-62. PubMed ID: 21606627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hydroxylated form of docosahexaenoic acid (DHA-H) modifies the brain lipid composition in a model of Alzheimer's disease, improving behavioral motor function and survival.
    Mohaibes RJ; Fiol-deRoque MA; Torres M; Ordinas M; López DJ; Castro JA; Escribá PV; Busquets X
    Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1596-1603. PubMed ID: 28284721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions.
    Hashimoto M; Hossain S; Agdul H; Shido O
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):91-8. PubMed ID: 16427803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous Docosahexaenoic Acid (DHA) Prevents Aβ1-42 Oligomer-Induced Neuronal Injury.
    Tan Y; Ren H; Shi Z; Yao X; He C; Kang JX; Wan JB; Li P; Yuan TF; Su H
    Mol Neurobiol; 2016 Jul; 53(5):3146-3153. PubMed ID: 26021747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docosahexaenoic acid: one molecule diverse functions.
    Hashimoto M; Hossain S; Al Mamun A; Matsuzaki K; Arai H
    Crit Rev Biotechnol; 2017 Aug; 37(5):579-597. PubMed ID: 27426008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arachidonic or Docosahexaenoic Acid Diet Prevents Memory Impairment in Tg2576 Mice.
    Hosono T; Mouri A; Nishitsuji K; Jung CG; Kontani M; Tokuda H; Kawashima H; Shibata H; Suzuki T; Nabehsima T; Michikawa M
    J Alzheimers Dis; 2015; 48(1):149-62. PubMed ID: 26401936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor γ activation.
    Chang HY; Lee HN; Kim W; Surh YJ
    Life Sci; 2015 Jan; 120():39-47. PubMed ID: 25445227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of docosahexaenoic acid on in vitro amyloid beta peptide 25-35 fibrillation.
    Hashimoto M; Shahdat HM; Katakura M; Tanabe Y; Gamoh S; Miwa K; Shimada T; Shido O
    Biochim Biophys Acta; 2009 Apr; 1791(4):289-96. PubMed ID: 19416653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?
    Pan Y; Khalil H; Nicolazzo JA
    Curr Clin Pharmacol; 2015; 10(3):222-41. PubMed ID: 26338174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.